New bone graft material could improve spine surgery outcomes
NCT ID NCT03853356
First seen Jun 25, 2026 · Last updated Jun 26, 2026 · Updated 1 time
Summary
This study is testing a material called Orthoss®, made from granules, to help bones in the spine fuse together after surgery. The trial includes 65 adults with lower back problems like slipped discs or narrowing of the spine canal. Doctors will check if the bones fuse properly and if patients feel better over 24 months.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Orthoss® granules (bone graft extender)
What this could lead to
If successful, Orthoss® could provide a safe and effective option to help spine bones fuse together after surgery, potentially reducing the need for additional bone grafts.
What could go wrong
This is a small, early-stage study (65 people) with no control group, so results may not apply broadly. The main risk is that the fusion may not occur as expected, requiring further surgery.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LUMBAR SPINAL STENOSIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Klinikum Magdeburg gGmbH
Magdeburg, Germany
-
Universitätsklinikum Augsburg - Neurochirurgische Klinik und Poliklinik
Augsburg, Germany
-
Universitätsklinikum Düsseldorf
Düsseldorf, Germany